Page 13 - Tests Performed News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Kapat “A total of 6,038 tests were carried out. There were 27 positive cases, of which 22 were local.  One person died and 26 people were discharged.” The number of tests performed in the last 24 hours was 6,038. There were 27 positive cases, of which 22 were local.  One person died and 26 people were discharged. 03 Mart 2021 Çarşamba 19:20 115 Okunma 2 people came to our country by air while 3 people are previously identified contacts of cases and are being kept under observation during this period.  22 people are local cases. 9 people are from Lefkoşa, 14 peopl...

Ara “A total of 7,435 tests were carried out. There were 35 positive cases, of which 27 were local. 54 people were discharged.” KKTC 02 Mart 2021 Salı 20:59 The number of tests performed in the last 24 hours was 7,435. There were 35 positive cases, of which 27 were local. 54 people were discharged. [Of the positive cases] 3 people came to our country by air while 5 people are previously identified contacts of cases and are being kept under observation during this period. 27 people are local cases. 23 people are from Lefkoşa, 8 people are from Girne, and 1 person is from the Gazimağusa ...

NeoGenomics, Inc.: NeoGenomics Reports 18% Revenue Growth to $126 Million in the Fourth Quarter Consolidated revenue increased 18% to $126 million Clinical Services revenue increased 14% to $107 million Pharma Services revenue increased 43% to $19 million Pharma Services backlog increased 60% to $209 million FT. MYERS, FL / ACCESSWIRE / February 24, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, today announced fourth-quarter and full-year 2020 results for the period ended December 31, 2020. Douglas M. VanOort, the company's Chairman and...

Share this article Share this article ResearchAndMarkets.com's offering. The global cardiac marker testing market is projected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2020, at a CAGR of 8.9%. The growth in the cardiac marker testing market is majorly driven by the growing incidence of cardiovascular diseases, rapidly increasing geriatric population, growing funding from public and private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers. However, factors such as technical problems related to sampl...